Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells

Anti-Cancer Drugs

Volumn 19, Issue 2, 2008, Pages 125-132

  Zhang, Haiyuan ^a   Wu, Jiu Sheng ^a   Peng, Fangyu ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle; Copper; Neuroblastoma; Pyrrolidine dithiocarbamate

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COPPER COMPLEX; PROTEIN P53; PYRROLIDINE DITHIOCARBAMATE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CYTOTOXICITY; DRUG MECHANISM; ELECTROSPRAY; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; COPPER; CYTOTOXINS; DNA; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; G2 PHASE; HUMANS; IMMUNOBLOTTING; INHIBITORY CONCENTRATION 50; MICROSCOPY, PHASE-CONTRAST; MOLECULAR STRUCTURE; NEUROBLASTOMA; PYRROLIDINES; S PHASE; THIOCARBAMATES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37849040263     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3282f2bdff     Document Type: Article

References (35)

1. Seeger RC, Reynolds CP. Neoplasms in children: neuroblastoma. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer medicine. Philadelphia: Lea & Febiger; 1993. pp. 2172-2184.
2. Olshan AF, Bunin GR. Epidemiology of neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, editors. Neuroblastoma. New York: Elsevier; 2000. pp. 33-37.
3. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95:1276-1299.
4. Hartmann O, Pinckerton CR, Philip T, Zucker JM, Breatnach F. Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma. J Clin Oncol 1988; 6:44-50.
5. Rixe W, Ortuzar M, Alvarez R, Parker E, Reed K, Paull T. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's anticancer drug screen panel. Biochem Pharmacol 1996; 52:1855-1865.
6. Faraglia G, Fregona D, Sitran S, Giovagnini L, Marzano C, Baccichetti F, et al. Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay. J Inorg Biochem 2001; 83:31-40.
7. Marzano C, Fregona D, Baccichetti F, Trevisan A, Giovagnini L, Bordin F. Cytotoxicity and DNA damage induced by a new platinum(II) complex with pyridine and dithiocarbamate. Chem Biol Interact 2002; 140:215-229.
8. Marzano C, Trevisan A, Giovagnini L, Fregona D. Synthesis of a new platinum(II) complex: anticancer activity and nephrotoxicity in vitro. Toxicol In Vitro 2002; 16:413-419.
9. Ronconi L, Marzano C, Zanello P, Corsini M, Miolo G, Macca C, et al. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. J Med Chem 2006; 49:1648-1657.
10. Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res 2005; 7:R897-R908.
11. Chen D, Peng F, Cui QZ, Daniel KG, Orlu S, Liu J, Dou QP. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Front Biosci 2005; 10:2932-2939.
12. Furuta S, Ortiz F, Zhu Sun X, Wu HH, Mason A, Momand J. Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. Biochem J 2002; 365:639-648.
13. Burkitt MJ, Bishop HS, Milne L, Tsang SY, Provan GJ, Nobel CS, et al. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch Biochem Biophys 1998; 353:73-84.
14. Nobel CS, Burgess DH, Zhivotovsky B, Burkitt MJ, Orrenius S, Slater AF. Mechanism of dithiocarbamate inhibition of apoptosis: thiol oxidation by dithiocarbamate disulfides directly inhibits processing of the caspase-3 proenzyme. Chem Res Toxicol 1997; 10:636-643.
15. Nobel CI, Kimland M, Lind B, Orrenius S, Slater AF. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redoxactive copper. J Biol Chem 1995; 270:26202-26208.
16. Schrech R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor B activation in intact cells. J Exp Med 1992; 175:1181-1194.
17. Erl W, Weber C, Hansson GK. Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(II) and Zn(II). Am J Physiol Cell Physiol 2000; 278:C1116-C1125.
18. Pyatt W, Yang Y, Le A, Stillman WS, Irons RD. Dithiocarbamate inhibits hematopoiesis via a copper-dependent mechanism. Biochem Biophys Res Commun 2000; 274:513-518.
19. Bian X, Opipari AW Jr, Ratanaproeksa AB, Boitano AE, Lucas PC, Castle VP. Constitutively active NFkappa B is required for the survival of S-type neuroblastoma. J Biol Chem 2002; 277:42144-42150.
20. Kania J, Baranska A, Guzdek A. Cytokine action and oxidative stress response in differentiated neuroblastoma SH-SY5Y cells. Acta Biochim Pol 2003; 50:659-666.
21. Lin KI, Lee SH, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol 1995; 131:1149-1161.
22. Shakya R, Peng F, Liu J, Heeg MJ, Verani CN. Synthesis, structure, and anticancer activity of gallium(III) complexes with asymmetric tridentate ligands: growth inhibition and apoptosis induction of cisplatin-resistant neuroblastoma cells. Inorg Chem 2006; 45:6263-6268.
23. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radioiodinated protein A. Anal Biochem 1981; 112:195-203.
24. Brown DA, Glass WK, Burke MA. The general use of IR spectral criteria in discussion of bonding and structures of metal dithiocarbamate. Spectrochim Acta 1976; 32A:137-143.
25. Nakamoto N, Fujita J, Condrote RA, Morimoto Y. Infrared spectra of metal chelate compounds. IX. A normal coordinate analysis of dithiocarbamate complexes. J Chem Phys 1963; 39:423-427.
26. Durgaprasad G, Sathyanarayana DN, Patel CC. Normal coordinate analysis of dialkyldithiocarbamate and its selenium analog. Can J Chem 1969; 47:631-635.
27. Herlinger AW, Wenhold SN, Lang TV. Infrared spectra of amino acids and their metal complexes. II. Geometrical isomerism in bis(amino acidato)copper(II) complexes. J Am Chem Soc 1970; 92:6474-6481.
28. Chatt J, Duncanson LA, Venazi LM. Dithiocarbamate, infrared spectra and structure. Suom Kemistil B 1956; 29:75-81.
29. Castillo M, Criado JJ, Marcias B, Vaquero MV. Chemistry of dithiocarbamate derivatives of amino acids. I. Study of some dithiocarbamate derivatives of linear α-amino acids and their nickel(II) complexes. Inorg Chim Acta 1986; 124:127-132.
30. 4 chromophores of dithiocarbamates derived from α-amino acids: synthesis, characterization and thermal behavior. Inorg Chim Acta 1989; 160:37-42.
31. Fabretti AF, Giusti A, Preti C, Tosi G, Zannini P. Synthesis and spectroscopic characterization of arsenic(III), antimony(III), bismuth(III), tin(II) and lead(II) dithiocarbamate adducts. Polyhedron 1986; 5:871-875.
32. Franchini GC, Giusti A, Preti C, Tassi L, Zannini P. Coordinating ability of methylpiperidine dithiocarbamates towards platinum group metals. Polyhedron 1985; 4:1553-1558.
33. Ngo SC, Banger KK, Delarosa MJ, Toscano PJ, Welch JT. Thermal and structural characterization of a series of homoleptic Cu(II) dialkyldithiocarbamate complexes: bigger is only marginally better for potential MOCVD performance. Polyhedron 2003; 22:1575-1583.
34. Newman PWG, Raston CL, White AH. Crystal structures of bis(pyrrolidonecarbodithioato)-nickel(II) and -copper(II). J Chem Soc Dalton Trans 1973; 13:1332-1335.
35. Tweddle DA, Pearsonb ADJ, Haberc M, Norrisc MD, Xue C, Flemming C, Lunec J. The p53 pathway and its inactivation in neuroblastoma. Cancer Lett 2003; 197:93-98.